The accuracy and feasibility of real-time continuous glucose monitoring (rt-CGM) in non-ICU hospitalized adult COVID-19 patients who had hyperglycemia requiring insulin therapy during admission. continuous glucose monitoring, COVID-19, accuracy
Conditions
Interventions
A trained researcher placed a 7 day Medtronic Guardian Connect real time CGM sensor and transmitter on the abdomen of patient.
Calibration was required 3 times per day on the first day then at least t
Experimental Device
Guardian Connect real time continuous glucose monitoring
Sponsors
Specific League Funds
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Hospitalized patients 18 years old of age or older 2. Positive COVID-19 RT-PCR test 3. Hyperglycemia requiring insulin therapy during admission in non-ICU units 4. Capability to use rt-CGMs and perform self-monitoring of CBG
Exclusion criteria
Exclusion criteria: 1. Coagulopathy (INR over 3) 2. Thrombocytopenia (platelet count less than 20,000/uL) 3. Hypotension (defined as BP less than 90/60 mmHg) or poor tissue perfusion 4. Multiorgan failure 5. Significant edema 6. Current treatment with dual antiplatelet therapy or medications known to interfere with the accuracy of CGMs such as hydroxyurea, intravenous ascorbic acid, paracetamol more than 4 grams in 24 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of CGM 7 days MARD | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of point of care blood glucose testing 7 days Times | — |
Countries
Thailand
Contacts
Public ContactNuntakorn Thongtang
Faculty of Medicine Siriraj Hospital, Mahidol University.
Outcome results
None listed